SCHEDULE 13G/A: Vanguard Group Discloses 4.66% Passive Stake in PetMed Express Inc.

The Vanguard Group has filed an amended Schedule 13G, reporting a 4.66% beneficial ownership stake in PetMed Express Inc. as of December 31, 2024.

Summary

• The Vanguard Group, an investment adviser, filed an Amendment No. 10 to its Schedule 13G regarding its beneficial ownership in PetMed Express Inc.
• As of December 31, 2024, The Vanguard Group beneficially owned 964,052 shares of PetMed Express Inc. Common Stock.
• This aggregate amount represents 4.66% of the class of securities.
• Vanguard holds sole dispositive power over 955,932 shares and shared dispositive power over 8,120 shares.
• The firm reported no sole or shared voting power over these shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The document is a routine beneficial ownership disclosure (Schedule 13G Amendment) by a passive institutional investor. It provides factual information about ownership percentages and does not contain operational or financial performance updates, thus maintaining a neutral sentiment.

Positives

• The continued holding by a major institutional investor like The Vanguard Group, even if passive and below 5%, indicates ongoing interest in PetMed Express Inc.

Negatives

• The filing does not contain any negative information regarding PetMed Express Inc.'s operations or financial performance, as it is solely an ownership disclosure.

Future Outlook

NA

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11." (Certification by Ashley Grim, Head of Global Fund Administration for The Vanguard Group)

Industry Context

This filing is a routine disclosure by a large asset manager, The Vanguard Group, detailing its passive investment stake in PetMed Express Inc., a company operating in the pet pharmaceutical and supply industry. Such filings are common for institutional investors managing broad portfolios.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake, confirming The Vanguard Group's continued, passive investment in the company.

Key Dates

Keywords

PetMed Express Inc., Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, Passive Investment